Skip to main content

Table 1 Assessment schedule

From: Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

Week

BL

Tx

W24

W25

W26

W27

W28

W30

W34

W38

W42

W46

W52

Informed consent

X

            

Medical history

X

X

           

Transplantation information

 

X

           

Concomitant medication

X

X

X

X

X

X

X

X

X

X

X

X

X

Physical examination

X

X

X

X

X

X

X

X

X

X

X

X

X

Routine lab

X

X

X

X

X

X

X

X

X

X

X

X

X

Urinalysis

X

X

X

X

X

X

X

X

X

X

X

X

X

CMV, EBV and BK viral load

  

X

X

 

X

 

X

 

X

 

X

X

MSC infusion

   

X

X

        

Renal biopsy

 

X

X

         

X

Iohexol clearance

  

X

         

X

Immune monitoring

 

X

X

Xa

Xa

X

  

X

   

X

DSA

X

X

X

    

X

    

X

Safety assesment

X

X

X

X

X

X

X

X

X

X

X

X

X

  1. BL baseline, Tx renal transplantation
  2. abefore and 4 h after MSC infusion